Literature DB >> 17382880

AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2.

Shobha Vasudevan1, Joan A Steitz.   

Abstract

AU-rich elements (AREs), present in mRNA 3'-UTRs, are potent posttranscriptional regulatory signals that can rapidly effect changes in mRNA stability and translation, thereby dramatically altering gene expression with clinical and developmental consequences. In human cell lines, the TNFalpha ARE enhances translation relative to mRNA levels upon serum starvation, which induces cell-cycle arrest. An in vivo crosslinking-coupled affinity purification method was developed to isolate ARE-associated complexes from activated versus basal translation conditions. We surprisingly found two microRNP-related proteins, fragile-X-mental-retardation-related protein 1 (FXR1) and Argonaute 2 (AGO2), that associate with the ARE exclusively during translation activation. Through tethering and shRNA-knockdown experiments, we provide direct evidence for the translation activation function of both FXR1 and AGO2 and demonstrate their interdependence for upregulation. This novel cell-growth-dependent translation activation role for FXR1 and AGO2 allows new insights into ARE-mediated signaling and connects two important posttranscriptional regulatory systems in an unexpected way.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382880      PMCID: PMC3430382          DOI: 10.1016/j.cell.2007.01.038

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  65 in total

Review 1.  HuR and mRNA stability.

Authors:  C M Brennan; J A Steitz
Journal:  Cell Mol Life Sci       Date:  2001-02       Impact factor: 9.261

Review 2.  The cap-to-tail guide to mRNA turnover.

Authors:  C J Wilusz; M Wormington; S W Peltz
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

Review 3.  Tumor necrosis factor or tumor promoting factor?

Authors:  Fran Balkwill
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

4.  RNA affinity tags for purification of RNAs and ribonucleoprotein complexes.

Authors:  Chatchawan Srisawat; David R Engelke
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

5.  Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo.

Authors:  Somashe Niranjanakumari; Erika Lasda; Robert Brazas; Mariano A Garcia-Blanco
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

Review 6.  Messenger RNA decay during aging and development.

Authors:  Gary Brewer
Journal:  Ageing Res Rev       Date:  2002-09       Impact factor: 10.895

7.  Evidence that microRNAs are associated with translating messenger RNAs in human cells.

Authors:  Patricia A Maroney; Yang Yu; Jesse Fisher; Timothy W Nilsen
Journal:  Nat Struct Mol Biol       Date:  2006-11-26       Impact factor: 15.369

8.  Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody.

Authors:  Keigo Ikeda; Minoru Satoh; Kaleb M Pauley; Marvin J Fritzler; Westley H Reeves; Edward K L Chan
Journal:  J Immunol Methods       Date:  2006-10-04       Impact factor: 2.303

9.  Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2.

Authors:  L L Kirkpatrick; K A McIlwain; D L Nelson
Journal:  Genomics       Date:  2001-12       Impact factor: 5.736

10.  Fragile X-related protein and VIG associate with the RNA interference machinery.

Authors:  Amy A Caudy; Mike Myers; Gregory J Hannon; Scott M Hammond
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

View more
  284 in total

1.  A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context.

Authors:  Chen-Chung Lin; Ling-Zhi Liu; Joseph B Addison; William F Wonderlin; Alexey V Ivanov; J Michael Ruppert
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

Review 2.  Control of cytokine mRNA expression by RNA-binding proteins and microRNAs.

Authors:  V Palanisamy; A Jakymiw; E A Van Tubergen; N J D'Silva; K L Kirkwood
Journal:  J Dent Res       Date:  2012-02-01       Impact factor: 6.116

3.  A 'pivotal' new rule for microRNA-mRNA interactions.

Authors:  Giovanni Stefani; Frank J Slack
Journal:  Nat Struct Mol Biol       Date:  2012-03-05       Impact factor: 15.369

4.  The potential functions of primary microRNAs in target recognition and repression.

Authors:  Robin Deis Trujillo; Si-Biao Yue; Yujie Tang; William E O'Gorman; Chang-Zheng Chen
Journal:  EMBO J       Date:  2010-08-31       Impact factor: 11.598

Review 5.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

6.  Demonstrating polymorphic miRNA-mediated gene regulation in vivo: application to the g+6223G->A mutation of Texel sheep.

Authors:  Haruko Takeda; Carole Charlier; Frédéric Farnir; Michel Georges
Journal:  RNA       Date:  2010-08-02       Impact factor: 4.942

Review 7.  microRNAs in heart disease: putative novel therapeutic targets?

Authors:  Gianluigi Condorelli; Michael V G Latronico; Gerald W Dorn
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

Review 8.  Deciphering the role of RNA-binding proteins in the post-transcriptional control of gene expression.

Authors:  Shivendra Kishore; Sandra Luber; Mihaela Zavolan
Journal:  Brief Funct Genomics       Date:  2010-12-01       Impact factor: 4.241

9.  FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124.

Authors:  Xia-Lian Xu; Ruiting Zong; Zhaodong Li; Md Helal Uddin Biswas; Zhe Fang; David L Nelson; Fen-Biao Gao
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

Review 10.  Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers.

Authors:  Vaishali Aggarwal; Kumari Priyanka; Hardeep Singh Tuli
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.